Calculator
mFluor™ Violet 505 SE
mFluor™ dyes are developed for multicolor flow cytometry-focused applications. These dyes have large Stokes Shifts, and can be well excited by the laser lines of flow cytometers (e.g., 405 nm, 488 nm and 633 nm). mFluor™ Violet dyes are optimized to be excited with a violet laser at 405 nm. AAT Bioquest offers the largest collection of fluorescent dyes that are excited by violet laser. mFluor™ Violet 505 dyes have fluorescence excitation and emission maxima of ~405 nm and ~505 nm respectively. These spectral characteristics make them a unique color for flow cytometry application. mFluor™ Violet 505 SE is reasonably stable and shows good reactivity and selectivity with protein amino groups. mFluor™ Violet 505 SE provides a convenient tool to label monoclonal, polyclonal antibodies or other proteins (>10 kDa) for flow cytometric applications with the violet laser excitation.
Example protocol
PREPARATION OF STOCK SOLUTIONS
Unless otherwise noted, all unused stock solutions should be divided into single-use aliquots and stored at -20 °C after preparation. Avoid repeated freeze-thaw cycles.
Note The pH of the protein solution (Solution A) should be 8.5 ± 0.5. If the pH of the protein solution is lower than 8.0, adjust the pH to the range of 8.0-9.0 using 1 M sodium bicarbonate solution or 1 M pH 9.0 phosphate buffer.
Note The protein should be dissolved in 1X phosphate buffered saline (PBS), pH 7.2-7.4. If the protein is dissolved in Tris or glycine buffer, it must be dialyzed against 1X PBS, pH 7.2-7.4, to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for protein precipitation.
Note Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well. The presence of sodium azide or thimerosal might also interfere with the conjugation reaction. Sodium azide or thimerosal can be removed by dialysis or spin column for optimal labeling results.
Note The conjugation efficiency is significantly reduced if the protein concentration is less than 2 mg/mL. For optimal labeling efficiency the final protein concentration range of 2-10 mg/mL is recommended.
Note Prepare the dye stock solution (Solution B) before starting the conjugation. Use promptly. Extended storage of the dye stock solution may reduce the dye activity. Solution B can be stored in freezer for two weeks when kept from light and moisture. Avoid freeze-thaw cycles.
1. Protein stock solution (Solution A)
Mix 100 µL of a reaction buffer (e.g., 1 M sodium carbonate solution or 1 M phosphate buffer with pH ~9.0) with 900 µL of the target protein solution (e.g. antibody, protein concentration >2 mg/mL if possible) to give 1 mL protein labeling stock solution.Note The pH of the protein solution (Solution A) should be 8.5 ± 0.5. If the pH of the protein solution is lower than 8.0, adjust the pH to the range of 8.0-9.0 using 1 M sodium bicarbonate solution or 1 M pH 9.0 phosphate buffer.
Note The protein should be dissolved in 1X phosphate buffered saline (PBS), pH 7.2-7.4. If the protein is dissolved in Tris or glycine buffer, it must be dialyzed against 1X PBS, pH 7.2-7.4, to remove free amines or ammonium salts (such as ammonium sulfate and ammonium acetate) that are widely used for protein precipitation.
Note Impure antibodies or antibodies stabilized with bovine serum albumin (BSA) or gelatin will not be labeled well. The presence of sodium azide or thimerosal might also interfere with the conjugation reaction. Sodium azide or thimerosal can be removed by dialysis or spin column for optimal labeling results.
Note The conjugation efficiency is significantly reduced if the protein concentration is less than 2 mg/mL. For optimal labeling efficiency the final protein concentration range of 2-10 mg/mL is recommended.
2. mFluor™ Violet 505 SE stock solution (Solution B)
Add anhydrous DMSO into the vial of mFluor™ Violet 505 SE to make a 10 mM stock solution. Mix well by pipetting or vortex.Note Prepare the dye stock solution (Solution B) before starting the conjugation. Use promptly. Extended storage of the dye stock solution may reduce the dye activity. Solution B can be stored in freezer for two weeks when kept from light and moisture. Avoid freeze-thaw cycles.
SAMPLE EXPERIMENTAL PROTOCOL
This labeling protocol was developed for the conjugate of Goat anti-mouse IgG with mFluor™ Violet 505 SE. You might need further optimization for your particular proteins.
Note Each protein requires distinct dye/protein ratio, which also depends on the properties of dyes. Over labeling of a protein could detrimentally affects its binding affinity while the protein conjugates of low dye/protein ratio gives reduced sensitivity.
Note Each protein requires distinct dye/protein ratio, which also depends on the properties of dyes. Over labeling of a protein could detrimentally affects its binding affinity while the protein conjugates of low dye/protein ratio gives reduced sensitivity.
Run conjugation reaction
- Use 10:1 molar ratio of Solution B (dye)/Solution A (protein) as the starting point: Add 5 µL of the dye stock solution (Solution B, assuming the dye stock solution is 10 mM) into the vial of the protein solution (95 µL of Solution A) with effective shaking. The concentration of the protein is ~0.05 mM assuming the protein concentration is 10 mg/mL and the molecular weight of the protein is ~200KD.
Note We recommend to use 10:1 molar ratio of Solution B (dye)/Solution A (protein). If it is too less or too high, determine the optimal dye/protein ratio at 5:1, 15:1 and 20:1 respectively. - Continue to rotate or shake the reaction mixture at room temperature for 30-60 minutes.
Purify the conjugation
The following protocol is an example of dye-protein conjugate purification by using a Sephadex G-25 column.- Prepare Sephadex G-25 column according to the manufacture instruction.
- Load the reaction mixture (From "Run conjugation reaction") to the top of the Sephadex G-25 column.
- Add PBS (pH 7.2-7.4) as soon as the sample runs just below the top resin surface.
- Add more PBS (pH 7.2-7.4) to the desired sample to complete the column purification. Combine the fractions that contain the desired dye-protein conjugate.
Note For immediate use, the dye-protein conjugate need be diluted with staining buffer, and aliquoted for multiple uses.
Note For longer term storage, dye-protein conjugate solution need be concentrated or freeze dried.
Spectrum
Product family
| Name | Excitation (nm) | Emission (nm) | Extinction coefficient (cm -1 M -1) | Quantum yield | Correction Factor (260 nm) | Correction Factor (280 nm) |
| mFluor™ Violet 450 SE | 406 | 445 | 350001 | 0.811 | 0.338 | 0.078 |
| mFluor™ Violet 510 SE | 412 | 505 | 250001 | 0.861 | 0.464 | 0.366 |
| mFluor™ Violet 540 SE | 402 | 535 | 180001 | 0.211 | 1.326 | 0.543 |
| mFluor™ Violet 500 SE | 410 | 501 | 250001 | 0.811 | 0.769 | 0.365 |
| mFluor™ Violet 610 SE | 594 | 612 | 900001 | 0.31 | 0.532 | 0.66 |
| mFluor™ Violet 550 SE | 527 | 550 | 900001 | 0.311 | 0.474 | 0.306 |
| mFluor™ Violet 590 SE | 564 | 591 | 900001 | 0.221 | 0.632 | 0.329 |
| mFluor™ Violet 545 SE | 393 | 543 | 200001 | 0.151 | 1.08 | 0.496 |
| mFluor™ Violet 530 SE | 393 | 543 | 200001 | - | - | - |
Show More (1) | ||||||
References
View all 11 references: Citation Explorer
Simultaneous ventilation in the Covid-19 pandemic. A bench study.
Authors: Guérin, Claude and Cour, Martin and Stevic, Neven and Degivry, Florian and L'Her, Erwan and Louis, Bruno and Argaud, Laurent
Journal: PloS one (2021): e0245578
Authors: Guérin, Claude and Cour, Martin and Stevic, Neven and Degivry, Florian and L'Her, Erwan and Louis, Bruno and Argaud, Laurent
Journal: PloS one (2021): e0245578
Bench Assessment of Expiratory Valve Resistance of Current ICU Ventilators in Dynamic Conditions.
Authors: Pinède, Alexandre and Cour, Martin and Degivry, Florian and Louis, Bruno and Argaud, Laurent and Guérin, Claude
Journal: Respiratory care (2021): 610-618
Authors: Pinède, Alexandre and Cour, Martin and Degivry, Florian and Louis, Bruno and Argaud, Laurent and Guérin, Claude
Journal: Respiratory care (2021): 610-618
The Difference Between Set and Delivered Tidal Volume: A Lung Simulation Study.
Authors: Yamaguchi, Yoshikazu and Miyashita, Tetsuya and Matsuda, Yuko and Sasaki, Makoto and Takaki, Shunsuke and Kim, Stephani S and Tobias, Joseph D and Goto, Takahisa
Journal: Medical devices (Auckland, N.Z.) (2020): 205-211
Authors: Yamaguchi, Yoshikazu and Miyashita, Tetsuya and Matsuda, Yuko and Sasaki, Makoto and Takaki, Shunsuke and Kim, Stephani S and Tobias, Joseph D and Goto, Takahisa
Journal: Medical devices (Auckland, N.Z.) (2020): 205-211
Preparation and evaluation of fluorescent poly(p-phenyleneethylene) covalently coated microspheres with reactive sites for bioconjugation.
Authors: Sun, Lijuan and Xu, Haibo and Shao, Ya and Liu, Jiangxin and Fan, Li-Juan
Journal: Journal of colloid and interface science (2019): 362-370
Authors: Sun, Lijuan and Xu, Haibo and Shao, Ya and Liu, Jiangxin and Fan, Li-Juan
Journal: Journal of colloid and interface science (2019): 362-370
Effects of Leak Compensation on Patient-Ventilator Synchrony During Premature/Neonatal Invasive and Noninvasive Ventilation: A Lung Model Study.
Authors: Itagaki, Taiga and Chenelle, Christopher T and Bennett, Desmond J and Fisher, Daniel F and Kacmarek, Robert M
Journal: Respiratory care (2017): 22-33
Authors: Itagaki, Taiga and Chenelle, Christopher T and Bennett, Desmond J and Fisher, Daniel F and Kacmarek, Robert M
Journal: Respiratory care (2017): 22-33
Page updated on November 21, 2024
Safety data sheet